You have 9 free searches left this month | for more free features.

City

Seoul (1)

Wuxi (1)

Condition

Castration-resistant Prostate Cancer (1)

Early Gastric Cancer (1)

Gastric Adenoma (1)

Overall Status

Completed (1)

Enrolling by invitation (1)

Sign in for free

Phase

n/a (1)

phase 1/phase 2 (1)

Sponsor

Jiangnan University (1)

Yonsei University (1)

Collaborator

Affiliated Hospital of Jiangnan University (1)

Intervention

polaprezinc (2)

abiraterone (1)

rebamipide (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

polaprezinc

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)

Enrolling by invitation

Castration-resistant Prostate Cancer

Polaprezinc
Abiraterone

Wuxi, Jiangsu, China

Jiangnan University

Sep 18, 2022

Gastric Adenoma, Early Gastric Cancer Trial in Seoul (Polaprezinc, Rebamipide)

Completed

Gastric Adenoma
Early Gastric Cancer

Polaprezinc
Rebamipide

Seoul, Korea, Republic of

Sevrance hospital

Mar 25, 2019